Logo - International Journal of Pharmaceutical Compounding

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Sep/Oct 2021 - Volume 25, Number 5
View All Articles in Issue

Abstract:  A formulation for preparing Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, atropine sulfate, formulation, oral suspension, anticholinergic agent, antispasmodic agent, muscle spasms, belladonna alkaloid, d-hyoscyamine, l-hyoscyamine

Related Categories: FORMULATIONS, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4970

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products